Contracting NGOs to provide health care in developing countries improves services

August 18, 2005

Contracting non-governmental organisations (NGOs) to deliver health services in developing countries could provide better results than government provision of the same services, state the authors of a public health article in this week's issue of THE LANCET.

To achieve the health-related Millennium Development Goals, the delivery of heath services will need to improve. Contracting with non-state entities, including NGOs, as been proposed as means for improving health care delivery.

Benjamin Loevinsohn and April Harding (The World Bank, Washington, D.C., USA) reviewed the global experience of contracting with NGOs to deliver primary health or nutrition services. They looked at 10 studies and found that contracting, which cost between US$3 and US$6 per head per year, led to substantial, rapid improvements in these services. They found, for example, that service delivery contracts in Cambodia increased immunisation coverage by 40 percentage points compared to control districts. Six of the ten studies compared contractor performance with government provision of the same services. All six showed that the contractors were more effective than government, on the basis of several measures related to both quality of care and coverage of services. One study revealed that in India an NGO achieved a treatment completion rate for tuberculosis that was 14 percentage points higher than public services in a nearby area, and at a lower cost.

Dr Loevinsohn concludes: "...the current weight of evidence suggests that contracting with non-governmental entities will provide better results than government provision of the same services. Contracting should no longer be considered an untested intervention or so-called leap of faith."

In an accompanying comment Ian Magrath (Insitut Pasteur, Brussels, Belgium) states: "Health will not be improved unless the necessary infrastructure for effective service delivery to the poorest populations can be developed...Because of their limited resources, the implementation of effective measures to control poverty, illiteracy, and disease in most developing countries will require external assistance."
-end-
Contact: Dr Benjamin Loevinsohn, World Bank, 1818 H Street NW, Mailstop MC11-1106, Washington DC 20433, USA. T) +1 202 473 7948 bloevinsohn@worldbank.org

Comment: Dr Ian Magrath, International Network for Cancer Treatment and Research INCTR at Institut Pasteur, Rue Engeland 642, B-1180, Brussels, Belgium. T) +32 2 373 9325 imagrath@inctr.be

Lancet

Related Tuberculosis Articles from Brightsurf:

Scientists find new way to kill tuberculosis
Scientists have discovered a new way of killing the bacteria that cause tuberculosis (TB), using a toxin produced by the germ itself.

Blocking the iron transport could stop tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply.

Tuberculosis: New insights into the pathogen
Researchers at the University of W├╝rzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.

Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.

Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.

A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.

How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.

Read More: Tuberculosis News and Tuberculosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.